| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 13,950,400 | 14,072,900 | 14,320,200 | | Cost of Revenue | 8,650,700 |
-
| 8,424,800 | | | Gross Profit | 5,299,700 | 14,072,900 | 5,895,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,608,700 | 10,995,400 | 2,784,300 | | Non Recurring | 14,318,100 |
-
| 65,200 | | Others | 531,600 | 455,700 | 439,500 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (12,158,700) | 2,621,800 | 2,606,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 130,200 | 82,100 | 91,800 | | Earnings Before Interest And Taxes | (12,028,500) | 2,703,900 | 2,698,200 | | Interest Expense | 546,600 | 570,900 | 565,500 | | Income Before Tax | (12,575,100) | 2,133,000 | 2,132,700 | | Income Tax Expense | (919,300) | 821,500 | 652,200 | | Minority Interest |
-
| (100) | (600) | | | | Net Income From Continuing Ops | (11,673,400) | 1,230,800 | 1,382,900 | | | Non-recurring Events | | Discontinued Operations |
-
| 16,200 | 277,600 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,673,400) | 1,247,000 | 1,660,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,673,400) | $1,247,000 | $1,660,500 |
|
0.14% Nasdaq 0.00%
Income Statement
